piracetam has been researched along with Action Tremor in 11 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Excerpt | Relevance | Reference |
---|---|---|
"In a double-blind crossover study we evaluated the antitremor effect of a 4-week treatment with either escalating dosages of levetiracetam or placebo in orthostatic tremor." | 9.15 | Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study. ( Deuschl, G; Hellriegel, H; Raethjen, J; Volkmann, J, 2011) |
"To investigate the effects of levetiracetam, an antiepileptic drug, on tremor severity and related functionality in MS." | 9.14 | The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis. ( D'hooghe, MB; Feys, P; Helsen, WF; Nagels, G, 2009) |
"The aim of this study was to evaluate the activity measured by kinematic analysis, tolerability and efficacy of levetiracetam (LEV) in multiple sclerosis (MS) patients affected by cerebellar symptoms, in a randomized single-blind, placebo-controlled cross-over study." | 9.13 | Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study. ( Abuarqub, S; Brichetto, G; Capello, E; Sanguineti, V; Solaro, C, 2008) |
"The effect of piracetam, a cyclical derivative of GABA, was compared with that of a placebo in a double-blind study of 60 patients with post-concussional syndrome of 2-12 months' duration." | 9.04 | Piracetam in the treatment of post-concussional syndrome. A double-blind study. ( Hakamies, L; Hakkarainen, H, 1978) |
"In a double-blind crossover study we evaluated the antitremor effect of a 4-week treatment with either escalating dosages of levetiracetam or placebo in orthostatic tremor." | 5.15 | Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study. ( Deuschl, G; Hellriegel, H; Raethjen, J; Volkmann, J, 2011) |
"To investigate the effects of levetiracetam, an antiepileptic drug, on tremor severity and related functionality in MS." | 5.14 | The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis. ( D'hooghe, MB; Feys, P; Helsen, WF; Nagels, G, 2009) |
"The aim of this study was to evaluate the activity measured by kinematic analysis, tolerability and efficacy of levetiracetam (LEV) in multiple sclerosis (MS) patients affected by cerebellar symptoms, in a randomized single-blind, placebo-controlled cross-over study." | 5.13 | Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study. ( Abuarqub, S; Brichetto, G; Capello, E; Sanguineti, V; Solaro, C, 2008) |
"The effect of piracetam, a cyclical derivative of GABA, was compared with that of a placebo in a double-blind study of 60 patients with post-concussional syndrome of 2-12 months' duration." | 5.04 | Piracetam in the treatment of post-concussional syndrome. A double-blind study. ( Hakamies, L; Hakkarainen, H, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (18.18) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Salazar, R | 1 |
Miller, D | 1 |
Ferlazzo, E | 1 |
Morgante, F | 1 |
Rizzo, V | 1 |
Sciarrone, G | 1 |
Meduri, M | 1 |
Magaudda, A | 1 |
Girlanda, P | 1 |
Quartarone, A | 1 |
Feys, P | 1 |
D'hooghe, MB | 1 |
Nagels, G | 1 |
Helsen, WF | 1 |
Singh, S | 1 |
Schwankhaus, J | 1 |
Hellriegel, H | 1 |
Raethjen, J | 1 |
Deuschl, G | 1 |
Volkmann, J | 1 |
Azzopardi, L | 1 |
Quirk, J | 1 |
Abourazzak, S | 1 |
Chaouki, S | 1 |
Boubou, M | 1 |
Amrani, M | 1 |
Atmani, S | 1 |
Hida, M | 1 |
Striano, P | 1 |
Elefante, A | 1 |
Coppola, A | 1 |
Tortora, F | 1 |
Zara, F | 1 |
Minetti, C | 1 |
Striano, S | 1 |
Solaro, C | 1 |
Brichetto, G | 1 |
Capello, E | 1 |
Abuarqub, S | 1 |
Sanguineti, V | 1 |
Hakkarainen, H | 1 |
Hakamies, L | 1 |
4 trials available for piracetam and Action Tremor
Article | Year |
---|---|
The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
Topics: Administration, Oral; Adult; Anticonvulsants; Cross-Over Studies; Dose-Response Relationship, Drug; | 2009 |
Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Cross-Over Studies; Dizziness; Double-Blind Method; Female | 2011 |
Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study.
Topics: Biomechanical Phenomena; Cerebellum; Female; Humans; Levetiracetam; Male; Multiple Sclerosis; Nootro | 2008 |
Piracetam in the treatment of post-concussional syndrome. A double-blind study.
Topics: Brain Concussion; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Fatigue; Headache; | 1978 |
7 other studies available for piracetam and Action Tremor
Article | Year |
---|---|
Symptomatic palatal tremor of cortical origin due to stroke.
Topics: Adult; Anticonvulsants; Electroencephalography; Humans; Infarction, Middle Cerebral Artery; Levetira | 2013 |
Successful treatment of Holmes tremor by levetiracetam.
Topics: Anticonvulsants; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Tremor; Young A | 2008 |
Olfactory disturbance in Parkinson disease.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Biomarkers; Brain; | 2009 |
An acquired source of seizures.
Topics: Adult; Albendazole; Animals; Anti-Inflammatory Agents; Anticonvulsants; Antiparasitic Agents; Develo | 2012 |
[Involuntary movements in infantile cobalamin deficiency appearing during treatment].
Topics: Anemia, Megaloblastic; Atrophy; Brain; Consanguinity; Electroencephalography; Female; Humans; Hydrox | 2013 |
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor.
Topics: Brain Ischemia; Cerebral Hemorrhage; Humans; Infarction; Levetiracetam; Male; Middle Aged; Nootropic | 2007 |
[Piracetam in the modern pharmacotherapy of the Parkinson syndrome].
Topics: Female; Humans; Middle Aged; Parkinson Disease, Secondary; Piracetam; Pyrrolidinones; Tremor | 1978 |